Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily… - The Lancet, 2019 - thelancet.com
Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …

Eliminating cervical cancer: progress and challenges for high-income countries

JC Davies-Oliveira, MA Smith, S Grover, K Canfell… - Clinical Oncology, 2021 - Elsevier
Abstract In 2020, the World Health Organization launched a major initiative to eliminate
cervical cancer globally. The initiative is built around the three key pillars of human …

[HTML][HTML] The projected timeframe until cervical cancer elimination in Australia: a modelling study

MT Hall, KT Simms, JB Lew, MA Smith… - The Lancet Public …, 2019 - thelancet.com
Summary Background In 2007, Australia was one of the first countries to introduce a national
human papillomavirus (HPV) vaccination programme, and it has since achieved high …

Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage

JML Brotherton, PN Bloem - Best practice & research Clinical obstetrics & …, 2018 - Elsevier
Persistent oncogenic human papillomavirus (HPV) is the cause of cervical cancer, as well as
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …

Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination …

EPF Chow, A Carter, T Vickers, CK Fairley… - The Lancet Infectious …, 2021 - thelancet.com
Summary Background In Australia, the government-funded human papillomavirus (HPV)
vaccination programme was introduced in April, 2007, for girls and young women, and in …

Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review

PJ Maver, M Poljak - Vaccine, 2018 - Elsevier
Prophylactic human papillomavirus (HPV) vaccine represents a revolutionary step forward in
preventing HPV-related cancers, especially cervical carcinoma. Alongside appropriate …

Primary prevention of HPV through vaccination: update on the current global status

JML Brotherton, PLF Zuber, PJN Bloem - Current Obstetrics and …, 2016 - Springer
Ten years after the first licencing of a prophylactic human papillomavirus (HPV) vaccine, this
paper reviews global information on programme coverage, as reported to WHO and from the …

Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources

W Wang, S Kothari, M Baay, SM Garland… - Expert Review of …, 2022 - Taylor & Francis
Introduction Vaccine effectiveness and impact studies are typically observational, generating
evidence after vaccine launch in a real-world setting. For human papillomavirus (HPV) …

[HTML][HTML] Topical application of temperature-sensitive caerin 1.1 and 1.9 gel inhibits TC-1 tumor growth in mice

B Ma, J Yuan, S Chen, K Huang, Q Wang… - American journal of …, 2020 - ncbi.nlm.nih.gov
Genital warts, which are one of the most common sexually transmitted diseases (STDs),
result from persistent infection with human papillomavirus (HPV), especially subtypes 6 or …

Topical application of temperature-sensitive gel containing caerin 1.1 and 1.9 peptides on TC-1 tumour-bearing mice induced high-level immune response in the …

G Ni, X Liu, H Li, CE Fogarty, S Chen, P Zhang… - Frontiers in …, 2021 - frontiersin.org
The development of topical cream drugs that increase the immune activation of tumour-
infiltrating lymphocytes against tumour and chronic viral infection-associated lesions is of …